While these reports indicate that 7SK may serve as a potential biomarker and therapeutic cancer target, recently uncovered connections between 7SK and BAF also raise important questions regarding the involvement of 7SK in cancers characterized by BAF mutations, which are collectively present in more than 20% of human cancers (Hodges et al., 2016). The gene discussed is 7SK; the disease is cancer.